在风险异质的世界中控制胃癌
本文综述全球胃癌流行病学、一级预防(幽门螺杆菌检测与根除)和二级预防策略,并评估这些策略在不同风险和疾病负担地区改善胃癌结局的应用。
要点
- 一级预防聚焦于检测和根除幽门螺杆菌。
- 部分高发国家采用内镜或影像学筛查无症状人群。
- 低发国家日益采用癌前病变(如肠上皮化生)识别与监测。
核心结论
- 全球胃癌负担分布不均,需根据风险与疾病负担差异应用预防和疾病减轻策略以改善结局。
研究设计与样本
- 综述,旨在界定全球疾病流行病学、批判性评价预防与疾病减轻策略并评估其应用。
主要发现
- 一级预防策略聚焦于改善主要环境风险因素幽门螺杆菌的检测和根除。
- 部分高发国家已采用内镜或影像学筛查无症状普通人群作为二级预防手段。
- 低发国家正日益采用癌前病变(如肠上皮化生)个体的识别和针对性监测。
- 综述还强调了胃癌预防中现有知识空白以及新兴技术在早期检测和风险分层中的作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gastric cancer (GC) is a leading cause of global mortality but also a cancer whose footprint is highly unequal. This review aims to define global disease epidemiology, critically appraise strategies of prevention and disease attenuation, and assess how these strategies could be applied to improve outcomes from GC in a world of variable risk and disease burden. Strategies of primary prevention focus on improving the detection and eradication of the main environmental risk factor, Helicobacter pylori. In certain countries of high incidence, endoscopic or radiographic screening of the asymptomatic general population has been adopted as a means of secondary prevention. By contrast, identification and targeted surveillance of individuals with precancerous lesions (such as intestinal metaplasia) is being increasingly embraced in nations of low incidence. This review also highlights existing knowledge gaps in GC prevention as well as the role of emerging technologies for early detection and risk stratification.
引用
- Huang RJ, Laszkowska M, In H, et al. Controlling Gastric Cancer in a World of Heterogeneous Risk. Gastroenterology. 2023. PMID: 36706842. doi:10.1053/j.gastro.2023.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。